Medicare Enrolled

Dr. Donald Negroski, MD

Neurology · Sarasota, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
5741 BEE RIDGE RD STE 530, Sarasota, FL 34233
9414872160
In practice since 2006 (19 years)
NPI: 1073624102 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Negroski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Negroski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Negroski

Dr. Donald Negroski is a neurology in Sarasota, FL, with 19 years in practice. Based on federal Medicare data, Dr. Negroski performed 14,671 Medicare services across 904 unique beneficiaries.

Between the years covered by Open Payments, Dr. Negroski received a total of $1,439,282 from 68 pharmaceutical and/or device companies across 2072 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Negroski is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 7% volume in FL$ $1,439,282 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,671
Medicare services
Top 7% in FL for neurology
904
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~772 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit13,465$5$22
Office visit, established patient (30-39 min)587$88$209
Needle measurement of electrical activity in arm or leg muscles, complete study170$74$216
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face86$126$343
Office visit, established patient (20-29 min)85$57$141
Office visit, established patient, complex (40-54 min)73$128$281
New patient office visit, complex (60-74 min)36$147$396
Nerve conduction, 5-6 studies32$97$353
Nerve conduction, 9-10 studies30$152$546
New patient office visit (45-59 min)25$110$368
EEG, extended monitoring21$334$746
Nerve conduction, 3-4 studies19$82$286
Injection of anesthetic agent and/or steroid into upper neck and back of head nerve18$67$244
Nerve conduction, 11-12 studies13$181$641
Measurement of nerve conduction using visual stimulation testing with report11$50$447
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,439,282
Total received (2018-2024)
Avg $205,612/year across 7 years
Top 1% in FL for neurology
68
Companies
2,072
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,369,421 (95.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$51,062 (3.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,798 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$244,656
2023
$140,533
2022
$142,155
2021
$156,077
2020
$163,694
2019
$274,816
2018
$317,351

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$556,813
Biogen, Inc.
$353,656
GENZYME CORPORATION
$242,265
Genentech USA, Inc.
$63,283
Alexion Pharmaceuticals, Inc.
$59,524
Novartis Pharmaceuticals Corporation
$31,536
Celgene Corporation
$28,876
E.R. Squibb & Sons, L.L.C.
$15,577
Ares Trading SA
$11,873
Teva Pharmaceuticals USA, Inc.
$10,861
Merck Healthcare KGaA
$10,525
Janssen Pharmaceuticals, Inc
$9,268
Vanda Pharmaceuticals Inc.
$8,955
TG Therapeutics, Inc.
$6,701
SANOFI-AVENTIS U.S. LLC
$5,764
Janssen Global Services, LLC
$5,005
Genentech, Inc.
$4,481
Acorda Therapeutics, Inc
$3,057
TG THERAPEUTICS, INC.
$2,526
Bayer HealthCare Pharmaceuticals Inc.
$1,150
Banner Life Sciences, LLC
$816
Amgen Inc.
$757
Avanir Pharmaceuticals, Inc.
$619
Eisai Inc.
$498
Allergan Inc.
$466
SK Life Science, Inc.
$401
Sunovion Pharmaceuticals Inc.
$375
UCB, Inc.
$373
Supernus Pharmaceuticals, Inc.
$337
Lilly USA, LLC
$301
ABBVIE INC.
$255
GE HEALTHCARE
$248
ACADIA Pharmaceuticals Inc
$227
Adamas Pharmaceuticals, Inc.
$185
PFIZER INC.
$169
Mallinckrodt Enterprises LLC
$151
CSL Behring
$113
Egalet US Inc
$108
GE Healthcare
$95
Amneal Pharmaceuticals LLC
$92
Horizon Therapeutics plc
$81
BANNER LIFE SCIENCES, LLC
$69
US WorldMeds, LLC
$66
Grifols USA, LLC
$66
Mallinckrodt Hospital Products Inc.
$61
Mallinckrodt LLC
$57
Assertio Therapeutics, Inc.
$54
ARBOR PHARMACEUTICALS, INC.
$53
Upsher-Smith Laboratories LLC
$50
ASSERTIO THERAPEUTICS, Inc.
$44
Pernix Therapeutics Holdings, Inc.
$39
Lundbeck LLC
$38
Zyla Life Sciences
$36
LivaNova USA, Inc.
$29
Nevro Corp.
$26
Akcea Therapeutics, Inc.
$24
EISAI INC.
$23
Otsuka America Pharmaceutical, Inc.
$23
Kyowa Kirin, Inc.
$20
Medtronic USA, Inc.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$18
JAZZ PHARMACEUTICALS INC.
$18
Mylan Pharmaceuticals Inc.
$18
Neurocrine Biosciences, Inc.
$17
Impax Laboratories, Inc.
$16
Neuronetics, Inc.
$15
Mitsubishi Tanabe Pharma America, Inc.
$13
Piramal Imaging Limited
$9
Top 3 companies account for 80.1% of total payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Bafiertam · Betaseron · Briviact · COPAXONE · CREXONT · Cambia · EMGALITY · Enspryng · Evobrutinib · Fycompa · GAZYVA · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · Gralise · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MS DISEASE STATE · Mavenclad · NAMZARIC · NEURACEQ · NEUROSTAR TMS THERAPY · NO PRODUCT DISCUSSED · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · Nayzilam · Neupro · OCREVUS · OXTELLAR XR · Ocrevus · Omnia · Ozanimod · PLEGRIDY · PONVORY · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · REXULTI · RYTARY · Radicava · Rebif · SILENOR · SOLIRIS · SPRIX · SUNOSI · SYNCHROMED · Soliris · TECFIDERA · TEGSEDI · TREXIMET · TROKENDI XR · TYSABRI · Trintellix · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VIIBRYD · VNS Therapy · VRAYLAR · VUMERITY · Vimpat · XCOPRI · Xadago · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZORVOLEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (95%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in FL.

Equivalent to $9,810 per 100 Medicare services performed
Looking for a neurology in Sarasota?
Compare neurologys in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
37
Per 100K population
8.2
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Negroski is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Negroski experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Negroski performed 13,465 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Negroski receive payments from pharmaceutical companies?
Yes. Dr. Negroski received a total of $1,439,282 from 68 companies across 2,072 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Negroski's costs compare to other neurologys in Sarasota?
Dr. Negroski's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Negroski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →